60 DEGREES PHARMACEUTICALS INC. - COMMON STOCK
0.2187
08-五月-24 15:57:07
15 分钟延时
股票
+0.0172
+8.54%
今日范围
0.2020 - 0.2352
ISIN
N/A
来源
NASDAQ
-
08 5月 2024 07:59:00 条件 Nasdaq GlobeNewswire
-
02 5月 2024 07:59:00 条件 Nasdaq GlobeNewswire
-
60 Degrees Pharmaceuticals to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis
03 4月 2024 07:58:00 条件 Nasdaq GlobeNewswire
-
14 3月 2024 07:59:00 条件 Nasdaq GlobeNewswire
-
20 2月 2024 07:59:00 条件 Nasdaq GlobeNewswire
-
60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief Commercial Officer
08 2月 2024 07:59:00 条件 Nasdaq GlobeNewswire
-
60 Degrees Pharmaceuticals Announces Closing of $2.4 Million Public Offering
31 1月 2024 11:15:00 条件 Nasdaq GlobeNewswire
-
60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million Public Offering
30 1月 2024 09:00:00 条件 Nasdaq GlobeNewswire
-
60 Degrees Pharma Plans Pivotal Babesiosis Study with Tafenoquine Following Jan 17 FDA Meeting
22 1月 2024 07:59:00 条件 Nasdaq GlobeNewswire
-
60 Degrees Pharma Regains Compliance with Nasdaq Listing Requirements
16 1月 2024 07:59:00 条件 Nasdaq GlobeNewswire
-
15 11月 2023 07:29:00 条件 Nasdaq GlobeNewswire
-
19 10月 2023 08:31:00 条件 Nasdaq GlobeNewswire
-
12 10月 2023 16:16:00 条件 Nasdaq GlobeNewswire
-
18 9月 2023 16:16:00 条件 Nasdaq GlobeNewswire
-
06 9月 2023 07:31:00 条件 Nasdaq GlobeNewswire
-
30 8月 2023 07:32:00 条件 Nasdaq GlobeNewswire
-
22 8月 2023 07:31:00 条件 Nasdaq GlobeNewswire
-
15 8月 2023 07:31:00 条件 Nasdaq GlobeNewswire
-
31 7月 2023 07:59:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >